Scarica l'app Stockscreener
23.80
1.00%
-0.24
Dopo l'orario di chiusura:
23.80
Janux Therapeutics Inc Borsa (JANX) Ultime notizie
SA Asks: Which oncology companies are attractive M&A targets? - Seeking Alpha
Nuveen Asset Management LLC Sells 39,145 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Millennium Management LLC Invests $6.22 Million in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
BNP Paribas Financial Markets Purchases New Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
When the Price of (JANX) Talks, People Listen - news.stocktradersdaily.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Given Average Rating of “Buy” by Analysts - Defense World
How Vir CEO Marianne De Backer Is Rebuilding Commercial Momentum - insights.citeline.com
Janux appoints Janeen Doyle chief corporate, business development officer - TipRanks
Janux Therapeutics (JANX) Welcomes New Chief Corporate and Busin - GuruFocus
Janux Therapeutics (JANX) Welcomes New Chief Corporate and Business Development Officer | JANX Stock News - GuruFocus
Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer - Bluefield Daily Telegraph
Northern Trust Corp Buys 42,302 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Cantor Fitzgerald Brokers Raise Earnings Estimates for JANX - Defense World
Q2 EPS Estimate for Janux Therapeutics Boosted by Analyst - Defense World
Janux Therapeutics Reports Increased Q1 Losses Amid R&D Expansion - TipRanks
Trend Tracker for (JANX) - news.stocktradersdaily.com
Leerink cuts Janux Therapeutics price target to $89, keeps Outperform By Investing.com - Investing.com India
Janux Therapeutics Inc (JANX) Gets a Hold from Scotiabank - The Globe and Mail
Promising Pipeline and Strategic Advancements Justify Buy Rating for Janux Therapeutics Inc - TipRanks
Janux Therapeutics price target lowered to $36 from $41 at Scotiabank - TipRanks
Janux Therapeutics (JANX) Reports Q1 EPS Loss, Maintains Strong Cash Position - GuruFocus
Scotiabank Adjusts Janux Therapeutics (JANX) Price Target Amid T - GuruFocus
Positive Buy Rating for Janux Therapeutics Inc. Driven by Promising Clinical Data and Strong Financial Position - TipRanks
Decoding Janux Therapeutics Inc (JANX): A Strategic SWOT Insight - GuruFocus
Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace
Janux Therapeutics Inc: Undervalued Growth Potential Amid Recent Stock Pullback - TipRanks
Janux Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Janux Therapeutics (JANX) Advances Clinical Trials for JANX007 | JANX Stock News - GuruFocus
Janux Therapeutics reports Q1 EPS (38c), consensus (39c) - TipRanks
BRIEF-Janux Therapeutics Q1 Basic EPS USD -0.38 - TradingView
Buy Rating for Janux Therapeutics Inc. Driven by Strategic Advancements in Prostate Cancer Treatment with JANX007 - TipRanks
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down After Insider Selling - Defense World
Buy Rating for Janux Therapeutics Inc: Promising PFS Data and Attractive Valuation - TipRanks
Janux commences Phase Ib studies in trial for prostate cancer treatment - Clinical Trials Arena
Buy Rating for Janux Therapeutics Inc: Promising Clinical Trial Results and Positive Outlook for JANX007 - TipRanks
Janux Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential - Insider Monkey
Janux Therapeutics begins phase 1b trial for prostate cancer therapy - Investing.com
Janux Therapeutics begins phase 1b trial for prostate cancer therapy By Investing.com - Investing.com India
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - Business Wire
Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Unknown Billionaire Phill Gross’ 10 Stock Picks with Huge Upside Potential - Insider Monkey
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
A new trading data show Janux Therapeutics Inc (JANX) is showing positive returns. - Sete News
Learn to Evaluate (JANX) using the Charts - news.stocktradersdaily.com
Trading Day Review: Janux Therapeutics Inc (JANX) Loses Momentum, Closing at 32.05 - DWinneX
Should Janux Therapeutics Inc (NASDAQ: JANX) Rally After -123.74% Drop From High? - Marketing Sentinel
Wells Fargo & Company MN Grows Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Are Janux Therapeutics Inc’shares a good deal? - uspostnews.com
Latest Insider moments: Meyer Andrew Hollman, Janux Therapeutics Inc [JANX] Chief Business Officer sold 3,334 shares – Knox Daily - knoxdaily.com
Russell Investments Group Ltd. Buys 442 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics Inc (JANX) Worth Considering For The Next Few Weeks - Stocksregister
Legal & General Group Plc Boosts Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - American Banking and Market News
LPL Financial LLC Makes New $439,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):